Efficiency of transformation of lymphocytes by Epstein-Barr virus.

Abstract We explored host cell and viral factors which influence the susceptibility of lymphocytes to immortalization by the Epstein-Barr virus (EBV). We found that immortalization by the B95-8 strain of EBV follows “one-hit” kinetics. With a limiting dilution technique, approximately 1 in 20 virus particles is transforming when assayed on human umbilical cord leukocytes (HUCL). Mixed mononuclear leukocytes from adult human and marmoset blood are 100- and 1000-fold, respectively, less sensitive to immortalization than HUCL. Pretreatment of cord blood leukocytes with phytohemagglutinin results in a 50% increase in their transformability. Lipopolysaccharide (LPS) from Escherichia coli increases the number of transformation events observed by 300–500%. LPS appears to enhance transformation by mechanisms other than stimulation of cellular DNA synthesis. A transformed center assay employing either autochthonous lymphocytes or human placental cells as feeders was used to determine the number of umbilical cord cells which were immortalized. At multiplicities of infection of 30–100 particles per cell, multiplicities which saturate nearly all the susceptible cells, approximately 1 in 200 to 1 in 500 mixed mononuclear cells transformed. When the mixed population of cells was depleted of T lymphocytes, there was a fourfold increase in the number of transformed cells. When correction is made for the plating efficiency of transformed cord blood leukocytes, it is calculated that at least 10% of virus-exposed cells establish permanent lines. This number is probably still an underestimate since we have not yet used a population which is composed entirely of susceptible cells.

[1]  V. Nussenzweig,et al.  A POPULATION OF LYMPHOCYTES BEARING A MEMBRANE RECEPTOR FOR ANTIGEN-ANTIBODY-COMPLEMENT COMPLEXES , 1970, The Journal of experimental medicine.

[2]  G. Miller,et al.  Epstein-Barr Viral Antigen in Single Cell Clones of Two Human Leukocytic Lines , 1970, Journal of virology.

[3]  Y. Hinuma,et al.  Clonal transformation of human leukocytes by Epstein‐barr virus in soft agar , 1976, International journal of cancer.

[4]  G. Miller,et al.  Trypsinized Placental Cell Cultures for the Propagation of Viruses and as “Feeder Layers” , 1970, Journal of virology.

[5]  J. H. Pope,et al.  Assay of the infectivity of Epstein-Barr virus by transformation of human leucocytes in vitro. , 1972, The Journal of general virology.

[6]  J. Whang-peng,et al.  Transformation and chromosome changes induced by Epstein-Barr virus in normal human leukocyte cultures. , 1969, Proceedings of the National Academy of Sciences of the United States of America.

[7]  B. Strauss,et al.  Induction of permanently proliferating human lymphoblastoid lines by N-methyl-N'-nitro-N-nitrosoguanidine. , 1975, Cancer Research.

[8]  V. Nussenzweig,et al.  Enhanced binding of neuraminidase-treated sheep erythrocytes to human T lymphocytes. , 1973, Blood.

[9]  H. Fudenberg,et al.  Isolation of normal T cells in chronic lymphatic leukaemia. , 1973, Lancet.

[10]  P. Gerber,et al.  B-cell characteristics of human peripheral and cord blood lymphocytes transformed by Epstein-Barr virus. , 1974, Journal of the National Cancer Institute.

[11]  G. Miller,et al.  Establishment of Cell Lines from Normal Adult Human Blood Leukocytes by Exposure to Epstein-Barr Virus and Neutralization by Human Sera with Epstein-Barr Virus Antibody 1 , 1971, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[12]  G. Miller,et al.  Epstein-Barr virus: transformation, cytopathic changes, and viral antigens in squirrel monkey and marmoset leukocytes. , 1972, Proceedings of the National Academy of Sciences of the United States of America.

[13]  M. Epstein,et al.  Observations on the type of infection by epstein‐barr virus in peripheral lymphoid cells of patients with infectious mononucleosis , 1974, International journal of cancer.

[14]  V. Diehl,et al.  Herpes-Type Virus and Chromosome Marker in Normal Leukocytes after Growth with Irradiated Burkitt Cells , 1967, Science.

[15]  J. H. Monroe,et al.  Rapid Semiquantitative Method for Screening Large Numbers of Virus Samples by Negative Staining Electron Microscopy , 1970, Applied microbiology.

[16]  L. Reed,et al.  A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS , 1938 .

[17]  G. Möller,et al.  Selective induction of DNA synthesis in T and B lymphocytes. , 1972, Cellular immunology.

[18]  G. de‐Thé,et al.  Lymphoblastoid transformation and kinetics of appearance of viral nuclear antigen (EBNA) in cord‐blood lymphocytes infected by epstein‐barr virus (EBV) , 1975, International journal of cancer.

[19]  G. Miller,et al.  COMPARISON OF THE YIELD OF INFECTIOUS VIRUS FROM CLONES OF HUMAN AND SIMIAN LYMPHOBLASTOID LINES TRANSFORMED BY EPSTEIN-BARR VIRUS , 1973, The Journal of experimental medicine.

[20]  J. Robinson Assay for Epstein-Barr virus based on stimulation of DNA synthesis in mixed leukocytes from human umbilical cord blood , 1975, Journal of virology.

[21]  G. Klein,et al.  SURFACE MARKERS ON HUMAN B AND T LYMPHOCYTES , 1973, The Journal of experimental medicine.

[22]  A. Bøyum,et al.  Isolation of mononuclear cells and granulocytes from human blood. , 1968 .

[23]  M. Greaves,et al.  Epstein-Barr virus binding sites on lymphocyte subpopulations and the origin of lymphoblasts in cultured lymphoid cell lines and in the blood of patients with infectious mononucleosis , 1975 .

[24]  H. Wigzell,et al.  SURFACE MARKERS ON HUMAN T AND B LYMPHOCYTES , 1972, The Journal of experimental medicine.

[25]  J. H. Pope,et al.  Transformation of foetal human leukocytes in vitro by filtrates of a human leukaemic cell line containing herpes‐like virus , 1968 .